Discover

SKYE
Skye Bioscience, Inc.
0.54
1 x 0.52
6 x 0.54
bid
ask
+
0.00
0.39%
1 @ 04:00 PM
0.54 +0.00 (0.00%)
Ytd-27.88%
1y-84.59%
0.53
day range
0.54
0.28
52 week range
4.99
Open0.53Prev Close0.54Low0.53High0.54Mkt Cap19.01M
Vol103.17KAvg Vol157.95KEPS-1.44P/E-0.38Forward P/E-2.27
Beta1.75Short Ratio10.06Inst. Own86.03%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0650-d Avg0.67200-d Avg0.891yr Est18.00
Income Statement
Operating Expenses12.67M
Research and Development Expense7.94M
Selling, General and Administrative Expense4.74M
Operating Income-12.67M
Interest Expense2.20K
Net Income-12.51M
Net Income Common Stock-12.51M
Net Income Common Stock (USD)-12.51M
Consolidated Income-12.51M
Earnings per Basic Share-0.32
Earnings per Basic Share (USD)-0.32
Earnings per Diluted Share-0.32
Earning Before Interest & Taxes (EBIT)-12.51M
Earning Before Interest & Taxes (USD)-12.51M
Weighted Average Shares39.68M
Weighted Average Shares Diluted39.68M
Balance Sheet
Cash and Equivalents8.15M
Cash and Equivalents (USD)8.15M
Investments8.96M
Investments Current8.96M
Current Assets18.57M
Property, Plant & Equipment Net813.86K
Total Assets19.42M
Debt Current311.32K
Total Debt311.32K
Current Liabilities10.40M
Total Liabilities10.40M
Accumulated Retained Earnings (Deficit)-199.38M
Shareholders Equity9.01M
Shareholders Equity (USD)9.01M
Assets Non-Current849.77K
Total Debt (USD)311.32K
Trade and Non-Trade Payables3.94M
Cash Flow
Depreciation, Amortization & Accretion172.89K
Net Cash Flow from Financing-71.53K
Net Cash Flow / Change in Cash & Cash Equivalents2.27M
Net Cash Flow - Business Acquisitions and Disposals850.00
Issuance (Repayment) of Debt Securities -71.53K
Net Cash Flow from Investing10.90M
Net Cash Flow - Investment Acquisitions and Disposals10.90M
Net Cash Flow from Operations-8.56M
Share Based Compensation1.50M